Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase
Autor(a) principal: | |
---|---|
Data de Publicação: | 2000 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Química Nova (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422000000600007 |
Resumo: | Complexation between acyclovir (ACV), an antiviral drug used for the treatment of herpes simplex virus infection, and beta-cyclodextrin (beta-CD) was studied in solution and in solid states. Complexation in solution was evaluated using solubility studies and nuclear magnetic resonance spectroscopy (¹H-NMR). In the solid state, X-ray diffraction, differential scanning calorimetry (DSC), thermal gravimetric analysis (TGA) and dissolution studies were used. Solubility studies suggested the existence of a 1:1 complex between ACV and beta-CD. ¹H-NMR spectroscopy studies showed that the complex formed occurs with a stoichiometry ratio of 1:1. Powder X-ray diffraction indicated that ACV exists in a semicrystalline state in the complexed form with beta-CD. DSC studies showed the existence of a complex of ACV with beta-CD. The TGA studies confirmed the DSC results of the complex. Solubility of ACV in solid complexes was studied by the dissolution method and it was found to be much more soluble than the uncomplexed drug. |
id |
SBQ-3_3678e21fae8c81b289c2d976ba671eef |
---|---|
oai_identifier_str |
oai:scielo:S0100-40422000000600007 |
network_acronym_str |
SBQ-3 |
network_name_str |
Química Nova (Online) |
repository_id_str |
|
spelling |
Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phasecyclodextrinacyclovirinclusion complexComplexation between acyclovir (ACV), an antiviral drug used for the treatment of herpes simplex virus infection, and beta-cyclodextrin (beta-CD) was studied in solution and in solid states. Complexation in solution was evaluated using solubility studies and nuclear magnetic resonance spectroscopy (¹H-NMR). In the solid state, X-ray diffraction, differential scanning calorimetry (DSC), thermal gravimetric analysis (TGA) and dissolution studies were used. Solubility studies suggested the existence of a 1:1 complex between ACV and beta-CD. ¹H-NMR spectroscopy studies showed that the complex formed occurs with a stoichiometry ratio of 1:1. Powder X-ray diffraction indicated that ACV exists in a semicrystalline state in the complexed form with beta-CD. DSC studies showed the existence of a complex of ACV with beta-CD. The TGA studies confirmed the DSC results of the complex. Solubility of ACV in solid complexes was studied by the dissolution method and it was found to be much more soluble than the uncomplexed drug.Sociedade Brasileira de Química2000-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422000000600007Química Nova v.23 n.6 2000reponame:Química Nova (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.1590/S0100-40422000000600007info:eu-repo/semantics/openAccessRossel,Carlos von PlessingSepúlveda Carreño,JacquelineRodríguez-Baeza,MarioAlderete,Joel Bernabéeng2001-01-18T00:00:00Zoai:scielo:S0100-40422000000600007Revistahttps://www.scielo.br/j/qn/ONGhttps://old.scielo.br/oai/scielo-oai.phpquimicanova@sbq.org.br1678-70640100-4042opendoar:2001-01-18T00:00Química Nova (Online) - Sociedade Brasileira de Química (SBQ)false |
dc.title.none.fl_str_mv |
Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase |
title |
Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase |
spellingShingle |
Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase Rossel,Carlos von Plessing cyclodextrin acyclovir inclusion complex |
title_short |
Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase |
title_full |
Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase |
title_fullStr |
Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase |
title_full_unstemmed |
Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase |
title_sort |
Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase |
author |
Rossel,Carlos von Plessing |
author_facet |
Rossel,Carlos von Plessing Sepúlveda Carreño,Jacqueline Rodríguez-Baeza,Mario Alderete,Joel Bernabé |
author_role |
author |
author2 |
Sepúlveda Carreño,Jacqueline Rodríguez-Baeza,Mario Alderete,Joel Bernabé |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Rossel,Carlos von Plessing Sepúlveda Carreño,Jacqueline Rodríguez-Baeza,Mario Alderete,Joel Bernabé |
dc.subject.por.fl_str_mv |
cyclodextrin acyclovir inclusion complex |
topic |
cyclodextrin acyclovir inclusion complex |
description |
Complexation between acyclovir (ACV), an antiviral drug used for the treatment of herpes simplex virus infection, and beta-cyclodextrin (beta-CD) was studied in solution and in solid states. Complexation in solution was evaluated using solubility studies and nuclear magnetic resonance spectroscopy (¹H-NMR). In the solid state, X-ray diffraction, differential scanning calorimetry (DSC), thermal gravimetric analysis (TGA) and dissolution studies were used. Solubility studies suggested the existence of a 1:1 complex between ACV and beta-CD. ¹H-NMR spectroscopy studies showed that the complex formed occurs with a stoichiometry ratio of 1:1. Powder X-ray diffraction indicated that ACV exists in a semicrystalline state in the complexed form with beta-CD. DSC studies showed the existence of a complex of ACV with beta-CD. The TGA studies confirmed the DSC results of the complex. Solubility of ACV in solid complexes was studied by the dissolution method and it was found to be much more soluble than the uncomplexed drug. |
publishDate |
2000 |
dc.date.none.fl_str_mv |
2000-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422000000600007 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422000000600007 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0100-40422000000600007 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Química |
publisher.none.fl_str_mv |
Sociedade Brasileira de Química |
dc.source.none.fl_str_mv |
Química Nova v.23 n.6 2000 reponame:Química Nova (Online) instname:Sociedade Brasileira de Química (SBQ) instacron:SBQ |
instname_str |
Sociedade Brasileira de Química (SBQ) |
instacron_str |
SBQ |
institution |
SBQ |
reponame_str |
Química Nova (Online) |
collection |
Química Nova (Online) |
repository.name.fl_str_mv |
Química Nova (Online) - Sociedade Brasileira de Química (SBQ) |
repository.mail.fl_str_mv |
quimicanova@sbq.org.br |
_version_ |
1750318101662007296 |